Dr. Sharpless has broad interests in abnormal psychology and psychotherapy. He has over 45 publications on common and lesser-known disorders, psychodynamic therapy, professional issues, and the history/philosophy of clinical psychology. His three books, Sleep Paralysis: Historical, Psychological, and Medical Perspectives (co-authored with Dr. Karl Doghramji), Unusual and Rare Psychological Disorders: A Handbook for Clinical Practice and Research, and Psychodynamic Therapy Techniques: A Guide to Expressive and Supportive Interventions are all available through Oxford University Press. This research been featured on TV, radio, and in other media outlets, and he is a frequent speaker at conferences and public events in the United States and abroad. Along with his scholarly interests, Dr. Sharpless also maintains a small private practice in the DC area.
Refreshments will be available.
At the speaker's request, this event will not be recorded for the NCAS YouTube channel.
December NCAS Lecture
John M. Butler, Special Assistant to the Director for Forensic Science at NIST, presents "Will DNA Testing Help My Family History Research?" Saturday, December 14 at 1:30 PM at Bethesda-Chevy Chase Regional Services Center.
FDA Call for Public Comments on Revised Draft Guidance for FDA Staff and Industry Entitled "Drug Products Labeled as Homeopathic"
The NCAS lecture of Saturday, January 11, 2020 (location TBD) will be presented by Nick Little, Vice President, General Counsel, and Legal Director of the Center for Inquiry on "The Little Non-Profit That Could – CFI’s challenge to pseudoscience and alternative medicine through consumer protection laws."
The following is an excerpt of Cause & Effect No. 142, November 6, 2019. (Cause & Effect is the biweekly newsletter of the Center for Inquiry community.)
Call to Experts: Tell the FDA to Get Tougher on Homeopathy
The Food and Drug Administration (FDA) is calling for public comments on its final version of new enforcement guidance for homeopathic “drug” manufacturers, replacing Compliance Policy Guidance (CPG) 400.400, which the agency last updated in March 1995. This new guidance espouses a “risk-based approach” to regulatory enforcement, which, while sounding sensible, comes at a time when we are seeing an across-the-board decline in FDA enforcement actions.
Homeopathic manufacturers may well interpret the “risk-based approach” as carte blanche to sell any product and make any health claim as long as they avoid only the most severe violations, such as claiming to cure terminal diseases or deliberately selling products with lethal quantities of toxic (i.e., “active”) ingredients. (And of course, homeopathy is premised on the dilution of said ingredients into virtual non-existence.)
The new guidance also completely omits the requirement for manufacturers to translate ingredient names from Latin to English. The previous guidance required manufacturers to do so no later than June 11, 1990, and went almost entirely ignored.
Homeopathy does not and
cannot work, and the FDA should be placing
more scrutiny on these products, not less. This is an opportunity to make your voice heard!
If you are a scientist, doctor, health care professional, or if you possess other relevant expertise, we highly encourage you to submit a public comment to the FDA.
We would also love to hear about your comment. Please consider sending us a brief email at
opp@centerforinquiry.org to let us know that you chimed in with the FDA.
Torn From Today's Headlines
By Scott Snell
The Transit of Mercury
Instead of its usual orbital passage somewhat north or south of the Sun's disk as seen from Earth, Mercury will pass directly in front of the Sun on November 11. It's the last time this event (a "transit of Mercury") will occur until 2032. But not until 2049 will a Mercury transit be visible again from the US.
The transit starts at 7:35 AM EST and ends at 1:04 PM. So far, the DC-area weather forecast for Monday is looking good ("mostly sunny").
A telescope or binoculars are required to see the planet's tiny silhouette. There isn't a safe way to combine eclipse glasses with either of those, so attend a viewing event hosted by the Smithsonian, local university astronomy departments, or amateur astronomy groups, some of which are listed below.
AmazonSmile: Thanks to our members who are supporting NCAS!
When shopping at
smile.amazon.com, you'll find the same low prices, vast selection, and convenient shopping experience as Amazon.com, with the added bonus that a portion of the purchase price (0.5%) goes to NCAS! It's simple and automatic, and it doesn't cost you anything!
AmazonSmile's disbursements to NCAS in the second quarter of 2019 came to $19.28, meaning that over $3800 of purchases were designated in support of NCAS. (As an example of how NCAS can put that money to good use, it's nearly enough to cover an hour of a Montgomery County lecture room rental.)
Thanks again to our members who have chosen to support NCAS!
For more information:
http://smile.amazon.com/about
http://phx.corporate-ir.net/phoenix.zhtml?c=176060&p=irol-newsArticle&ID=1870185
Shadow Light
Some members and contacts of NCAS receive a postal notification of this and every new monthly
Shadow of a Doubt. The
Shadow Light postcard announces the monthly lecture and highlights of the electronic
Shadow of a Doubt, which is available online at
ncas.org/shadow. NCAS thereby reduces
Shadow production and postage costs. To further reduce costs, members and contacts can opt out of postal notification altogether, while continuing to receive
Shadow of a Doubt via e-mail. To opt out, send us an e-mail at
ncas@ncas.org.
Time to Renew?
Be sure to check your renewal date above your postal address on the
Shadow Light postcard. Send any queries to
ncas@ncas.org. Use the
online membership form to renew.
http://ncas.org/shadow
